Published in Proc Natl Acad Sci U S A on October 15, 1992
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A (2006) 7.99
Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev (2002) 7.42
Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect Immun (1995) 5.35
Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog (2006) 5.17
The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat Rev Microbiol (2008) 4.09
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages. Infect Immun (1993) 3.97
Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages. Infect Immun (1999) 2.32
Utilization of similar mechanisms by Legionella pneumophila to parasitize two evolutionarily distant host cells, mammalian macrophages and protozoa. Infect Immun (1997) 2.29
Analysis of the Legionella pneumophila fliI gene: intracellular growth of a defined mutant defective for flagellum biosynthesis. Infect Immun (1997) 2.24
Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun (1996) 2.19
Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway. Infect Immun (1998) 2.15
The phagosome containing Legionella pneumophila within the protozoan Hartmannella vermiformis is surrounded by the rough endoplasmic reticulum. Appl Environ Microbiol (1996) 2.04
Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev (2010) 2.04
Identification of Legionella pneumophila mutants that have aberrant intracellular fates. Infect Immun (1996) 1.84
The Legionella pneumophila rpoS gene is required for growth within Acanthamoeba castellanii. J Bacteriol (1999) 1.76
Early events in phagosome establishment are required for intracellular survival of Legionella pneumophila. Infect Immun (1998) 1.75
Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect Immun (2000) 1.71
Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog (2008) 1.70
The Legionella pneumophila IcmSW complex interacts with multiple Dot/Icm effectors to facilitate type IV translocation. PLoS Pathog (2007) 1.67
MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease. Infect Immun (2006) 1.65
The Legionella pneumophila icmGCDJBF genes are required for killing of human macrophages. Infect Immun (1998) 1.62
A Dot/Icm-translocated ankyrin protein of Legionella pneumophila is required for intracellular proliferation within human macrophages and protozoa. Mol Microbiol (2008) 1.61
The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication. PLoS Pathog (2011) 1.58
Identification of macrophage-specific infectivity loci (mil) of Legionella pneumophila that are not required for infectivity of protozoa. Infect Immun (1998) 1.54
Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect Immun (2001) 1.50
Topology of Legionella pneumophila DotA: an inner membrane protein required for replication in macrophages. Infect Immun (1997) 1.46
Identification and subcellular localization of the Legionella pneumophila IcmX protein: a factor essential for establishment of a replicative organelle in eukaryotic host cells. Infect Immun (2000) 1.44
Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect Immun (1995) 1.42
Genetic and phenotypic differences between Legionella pneumophila strains. J Clin Microbiol (2002) 1.41
Legionella pneumophila contains a type II general secretion pathway required for growth in amoebae as well as for secretion of the Msp protease. Infect Immun (1999) 1.39
MTOR-Driven Metabolic Reprogramming Regulates Legionella pneumophila Intracellular Niche Homeostasis. PLoS Pathog (2016) 1.39
Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. PLoS Pathog (2013) 1.38
Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila. J Bacteriol (2008) 1.37
Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila. PLoS Pathog (2009) 1.37
Comparative and functional genomics of legionella identified eukaryotic like proteins as key players in host-pathogen interactions. Front Microbiol (2011) 1.35
Characterization of a Legionella pneumophila relA insertion mutant and toles of RelA and RpoS in virulence gene expression. J Bacteriol (2002) 1.35
Elevated levels of Legionella pneumophila stress protein Hsp60 early in infection of human monocytes and L929 cells correlate with virulence. Infect Immun (1996) 1.34
Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect Immun (2000) 1.31
Preventing bacterial DNA release and absent in melanoma 2 inflammasome activation by a Legionella effector functioning in membrane trafficking. Proc Natl Acad Sci U S A (2012) 1.30
Characterization of the icmH and icmF genes required for Legionella pneumophila intracellular growth, genes that are present in many bacteria associated with eukaryotic cells. Infect Immun (2004) 1.23
Multiplication of different Legionella species in Mono Mac 6 cells and in Acanthamoeba castellanii. Appl Environ Microbiol (1997) 1.21
Effector protein translocation by the Coxiella burnetii Dot/Icm type IV secretion system requires endocytic maturation of the pathogen-occupied vacuole. PLoS One (2013) 1.19
Bacterial Type IV secretion systems: versatile virulence machines. Future Microbiol (2012) 1.19
SigmaS controls multiple pathways associated with intracellular multiplication of Legionella pneumophila. J Bacteriol (2009) 1.19
Lipidation by the host prenyltransferase machinery facilitates membrane localization of Legionella pneumophila effector proteins. J Biol Chem (2010) 1.18
A 65-kilobase pathogenicity island is unique to Philadelphia-1 strains of Legionella pneumophila. J Bacteriol (2003) 1.18
A Legionella pneumophila effector protein encoded in a region of genomic plasticity binds to Dot/Icm-modified vacuoles. PLoS Pathog (2009) 1.17
Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila. Infect Immun (2010) 1.13
The Legionella pneumophila iraAB locus is required for iron assimilation, intracellular infection, and virulence. Infect Immun (2000) 1.12
Packaging of live Legionella pneumophila into pellets expelled by Tetrahymena spp. does not require bacterial replication and depends on a Dot/Icm-mediated survival mechanism. Appl Environ Microbiol (2008) 1.12
The DotL protein, a member of the TraG-coupling protein family, is essential for Viability of Legionella pneumophila strain Lp02. J Bacteriol (2005) 1.11
Modulation of ubiquitin dynamics and suppression of DALIS formation by the Legionella pneumophila Dot/Icm system. Cell Microbiol (2008) 1.09
Analysis of DNA regulatory elements required for expression of the Legionella pneumophila icm and dot virulence genes. J Bacteriol (2002) 1.08
The purified and recombinant Legionella pneumophila chaperonin alters mitochondrial trafficking and microfilament organization. Infect Immun (2009) 1.07
De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells. Infect Immun (1996) 1.06
Sensor kinases RetS and LadS regulate Pseudomonas syringae type VI secretion and virulence factors. J Bacteriol (2010) 1.06
Master manipulators: an update on Legionella pneumophila Icm/Dot translocated substrates and their host targets. Future Microbiol (2014) 1.06
The alternative sigma factor sigma28 of Legionella pneumophila restores flagellation and motility to an Escherichia coli fliA mutant. J Bacteriol (1997) 1.04
Compensatory functions of two alkyl hydroperoxide reductases in the oxidative defense system of Legionella pneumophila. J Bacteriol (2006) 1.03
Characterization of the major secreted zinc metalloprotease- dependent glycerophospholipid:cholesterol acyltransferase, PlaC, of Legionella pneumophila. Infect Immun (2005) 1.02
Potential virulence role of the Legionella pneumophila ptsP ortholog. Infect Immun (2001) 1.02
Multiple MyD88-dependent responses contribute to pulmonary clearance of Legionella pneumophila. Cell Microbiol (2008) 1.02
Phagocytosis of wild-type Legionella pneumophila occurs through a wortmannin-insensitive pathway. Infect Immun (2001) 1.01
Legionella pneumophila catalase-peroxidases are required for proper trafficking and growth in primary macrophages. Infect Immun (2003) 1.00
Identification of Coxiella burnetii type IV secretion substrates required for intracellular replication and Coxiella-containing vacuole formation. J Bacteriol (2013) 1.00
Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens. Proc Natl Acad Sci U S A (2015) 0.97
Increases in c-Jun N-terminal kinase/stress-activated protein kinase and p38 activity in monocyte-derived macrophages following the uptake of Legionella pneumophila. Infect Immun (2004) 0.97
Rapid escape of the dot/icm mutants of Legionella pneumophila into the cytosol of mammalian and protozoan cells. Infect Immun (2007) 0.97
Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila. J Exp Med (1998) 0.96
ArgR-regulated genes are derepressed in the Legionella-containing vacuole. J Bacteriol (2010) 0.96
AtlasT4SS: a curated database for type IV secretion systems. BMC Microbiol (2012) 0.95
Molecular cloning and characterization of a locus responsible for O acetylation of the O polysaccharide of Legionella pneumophila serogroup 1 lipopolysaccharide. J Bacteriol (1999) 0.95
Cyclic diguanylate signaling proteins control intracellular growth of Legionella pneumophila. MBio (2011) 0.94
The Legionella pneumophila effector VipA is an actin nucleator that alters host cell organelle trafficking. PLoS Pathog (2012) 0.93
Inflammasome-mediated cell death in response to bacterial pathogens that access the host cell cytosol: lessons from legionella pneumophila. Front Cell Infect Microbiol (2013) 0.90
Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth. J Biol Chem (2010) 0.90
Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion. Infect Immun (2014) 0.90
Control of host cell phosphorylation by legionella pneumophila. Front Microbiol (2011) 0.87
Virulence conversion of Legionella pneumophila by conjugal transfer of chromosomal DNA. J Bacteriol (2003) 0.87
MavN is a Legionella pneumophila vacuole-associated protein required for efficient iron acquisition during intracellular growth. Proc Natl Acad Sci U S A (2015) 0.86
The global regulatory proteins LetA and RpoS control phospholipase A, lysophospholipase A, acyltransferase, and other hydrolytic activities of Legionella pneumophila JR32. J Bacteriol (2006) 0.86
Characterization of Legionella pneumophila isolated from environmental water and ashiyu foot spa. Biomed Res Int (2013) 0.86
Prevalence and detailed mapping of the gonococcal genetic island in Neisseria meningitidis. J Bacteriol (2012) 0.85
Invasion of eukaryotic cells by Legionella pneumophila: A common strategy for all hosts? Can J Infect Dis (1997) 0.85
Polar localization of the Coxiella burnetii type IVB secretion system. FEMS Microbiol Lett (2010) 0.84
Mouse macrophages are permissive to motile Legionella species that fail to trigger pyroptosis. Infect Immun (2009) 0.84
Post-translational modifications are key players of the Legionella pneumophila infection strategy. Front Microbiol (2015) 0.84
Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. J Clin Microbiol (1998) 0.83
Efficient generation of unmarked deletions in Legionella pneumophila. Appl Environ Microbiol (2011) 0.83
Transcriptional down-regulation and rRNA cleavage in Dictyostelium discoideum mitochondria during Legionella pneumophila infection. PLoS One (2009) 0.82
The phtC-phtD locus equips Legionella pneumophila for thymidine salvage and replication in macrophages. Infect Immun (2013) 0.81
Structure and function of interacting IcmR-IcmQ domains from a type IVb secretion system in Legionella pneumophila. Structure (2009) 0.81
Characterization of Legionella pneumophila pmiA, a gene essential for infectivity of protozoa and macrophages. Infect Immun (2005) 0.81
Infection of cultured human endothelial cells by Legionella pneumophila. PLoS One (2008) 0.81
IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis. Proc Natl Acad Sci U S A (2015) 0.80
Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells. FEMS Microbiol Lett (2010) 0.80
Architecture of the type IV coupling protein complex of Legionella pneumophila. Nat Microbiol (2017) 0.80
LtpD is a novel Legionella pneumophila effector that binds phosphatidylinositol 3-phosphate and inositol monophosphatase IMPA1. Infect Immun (2013) 0.78
IcmQ in the Type 4b secretion system contains an NAD+ binding domain. Structure (2013) 0.77
Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants. Gene (1982) 20.39
Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J Clin Microbiol (1979) 15.15
Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest (1980) 12.41
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med (1983) 8.82
Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med (1983) 7.65
Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol (1984) 4.88
Physical and genetic studies with restriction endonucleases on the broad host-range plasmid RK2. Mol Gen Genet (1977) 4.28
Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell (1984) 4.00
Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. J Clin Invest (1983) 3.79
Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med (1987) 3.78
Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes. J Exp Med (1987) 3.13
Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol (1986) 2.62
Stable cosmid vectors that enable the introduction of cloned fragments into a wide range of gram-negative bacteria. Gene (1983) 2.55
Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes. Infect Immun (1988) 2.10
The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J Immunol (1990) 1.70
Characterization of the selective inhibition of growth of virulent Legionella pneumophila by supplemented Mueller-Hinton medium. Infect Immun (1989) 1.61
An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J Clin Invest (1990) 1.41
Isolation of a Legionella pneumophila restriction mutant with increased ability to act as a recipient in heterospecific matings. J Bacteriol (1989) 1.24
A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge. J Clin Invest (1989) 1.07
Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest (1980) 12.41
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med (1983) 8.82
Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med (1983) 7.65
Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med (1995) 6.62
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest (1980) 6.61
Host cell killing and bacterial conjugation require overlapping sets of genes within a 22-kb region of the Legionella pneumophila genome. Proc Natl Acad Sci U S A (1998) 5.65
Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol (1990) 5.39
Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol (1984) 4.88
Conversion of beta-galactosidase to a membrane-bound state by gene fusion. Proc Natl Acad Sci U S A (1976) 4.61
Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria. J Exp Med (1981) 4.08
Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell (1984) 4.00
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages. Infect Immun (1993) 3.97
Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85
Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. J Clin Invest (1983) 3.79
Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med (1987) 3.78
Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78
Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest (1984) 3.59
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52
Dominant constitutive mutations in malT, the positive regulator gene of the maltose regulon in Escherichia coli. J Mol Biol (1978) 3.46
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A (2001) 3.37
Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest (1989) 3.36
Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med (1981) 3.27
Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon. Mol Gen Genet (1979) 2.83
Active transport of maltose in Escherichia coli K12. Role of the periplasmic maltose-binding protein and evidence for a substrate recognition site in the cytoplasmic membrane. J Biol Chem (1982) 2.71
Phagocytosis of microorganisms. Rev Infect Dis (1982) 2.68
The Legionella pneumophila icm locus: a set of genes required for intracellular multiplication in human macrophages. Mol Microbiol (1994) 2.65
Labeling of proteins with beta-galactosidase by gene fusion. Identification of a cytoplasmic membrane component of the Escherichia coli maltose transport system. J Biol Chem (1980) 2.63
Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila. J Immunol (1986) 2.62
Mechanism of maltose transport in Escherichia coli: transmembrane signaling by periplasmic binding proteins. Proc Natl Acad Sci U S A (1992) 2.47
Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest (1995) 2.43
Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun (1996) 2.43
The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med (1996) 2.40
The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med (1996) 2.37
Isolation and characterization of the cytoplasmic and outer membranes of the Legionnaires' disease bacterium (Legionella pneumophila). J Exp Med (1985) 2.37
Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med (1996) 2.35
Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages. Infect Immun (1999) 2.32
Cell-mediated immunity in Legionnaires' disease. J Clin Invest (1983) 2.30
Characterization of a new region required for macrophage killing by Legionella pneumophila. Infect Immun (1997) 2.26
Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci U S A (1994) 2.26
Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins. Proc Natl Acad Sci U S A (1995) 2.17
Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes. Infect Immun (1988) 2.10
Relationships between a new type IV secretion system and the icm/dot virulence system of Legionella pneumophila. Mol Microbiol (1999) 1.99
Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med (1989) 1.91
Purification of Legionella pneumophila major outer membrane protein and demonstration that it is a porin. J Bacteriol (1985) 1.91
IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol (1988) 1.87
Genetic evidence for substrate and periplasmic-binding-protein recognition by the MalF and MalG proteins, cytoplasmic membrane components of the Escherichia coli maltose transport system. J Bacteriol (1985) 1.82
Identification of the malK gene product. A peripheral membrane component of the Escherichia coli maltose transport system. J Biol Chem (1981) 1.80
Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med (1990) 1.79
Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest (1993) 1.78
The Legionella pneumophila rpoS gene is required for growth within Acanthamoeba castellanii. J Bacteriol (1999) 1.76
Early events in phagosome establishment are required for intracellular survival of Legionella pneumophila. Infect Immun (1998) 1.75
Defective production of monocyte-activating cytokines in lepromatous leprosy. J Exp Med (1984) 1.74
How is the intracellular fate of the Legionella pneumophila phagosome determined? Trends Microbiol (1998) 1.73
The activities of the Escherichia coli MalK protein in maltose transport, regulation, and inducer exclusion can be separated by mutations. J Bacteriol (1991) 1.71
Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect Immun (2000) 1.71
The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J Immunol (1990) 1.70
Mutagenesis of Legionella pneumophila using Tn903 dlllacZ: identification of a growth-phase-regulated pigmentation gene. Mol Microbiol (1994) 1.69
Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68
Membrane sorting during phagocytosis: selective exclusion of major histocompatibility complex molecules but not complement receptor CR3 during conventional and coiling phagocytosis. J Exp Med (1992) 1.67
Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest (1990) 1.66
Icm/dot-dependent upregulation of phagocytosis by Legionella pneumophila. Mol Microbiol (2001) 1.66
Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci U S A (2000) 1.65
The Legionella pneumophila major secretory protein, a protease, is not required for intracellular growth or cell killing. Infect Immun (1990) 1.65
The Legionella pneumophila icmGCDJBF genes are required for killing of human macrophages. Infect Immun (1998) 1.62
Intracellular multiplication and human macrophage killing by Legionella pneumophila are inhibited by conjugal components of IncQ plasmid RSF1010. Mol Microbiol (1998) 1.60
Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect Immun (1999) 1.59
Overproduction of MalK protein prevents expression of the Escherichia coli mal regulon. J Bacteriol (1988) 1.58
Allele-specific malE mutations that restore interactions between maltose-binding protein and the inner-membrane components of the maltose transport system. J Mol Biol (1988) 1.57
Sites within gene lacZ of Escherichia coli for formation of active hybrid beta-galactosidase molecules. J Bacteriol (1979) 1.44
Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol (1995) 1.43
High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun (1997) 1.42
Amphipols: polymeric surfactants for membrane biology research. Cell Mol Life Sci (2003) 1.42
Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease. J Clin Invest (1993) 1.41
An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease. J Clin Invest (1990) 1.41
An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol (2001) 1.40
Legionella pneumophila contains a type II general secretion pathway required for growth in amoebae as well as for secretion of the Msp protease. Infect Immun (1999) 1.39
Characterization of the structural requirements for assembly and nucleotide binding of an ATP-binding cassette transporter. The maltose transport system of Escherichia coli. J Biol Chem (1993) 1.38
Outbreaks of waterborne disease in the United States, 1974. J Infect Dis (1976) 1.38
Expression and efficient export of enzymatically active Mycobacterium tuberculosis glutamine synthetase in Mycobacterium smegmatis and evidence that the information for export is contained within the protein. J Biol Chem (1997) 1.36
Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes. Infect Immun (1993) 1.35
Possible origin of the Legionella pneumophila virulence genes and their relation to Coxiella burnetii. Mol Microbiol (1999) 1.34
Mycobacterium tuberculosis and Legionella pneumophila phagosomes exhibit arrested maturation despite acquisition of Rab7. Infect Immun (2000) 1.31
Genetic analysis of periplasmic binding protein dependent transport in Escherichia coli. Each lobe of maltose-binding protein interacts with a different subunit of the MalFGK2 membrane transport complex. J Mol Biol (1993) 1.28
Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med (1991) 1.27
Mutations that alter the transmembrane signalling pathway in an ATP binding cassette (ABC) transporter. EMBO J (1994) 1.25
Isolation of a Legionella pneumophila restriction mutant with increased ability to act as a recipient in heterospecific matings. J Bacteriol (1989) 1.24
Identification of iron-regulated proteins of Mycobacterium tuberculosis and cloning of tandem genes encoding a low iron-induced protein and a metal transporting ATPase with similarities to two-component metal transport systems. Microb Pathog (1998) 1.22
A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect Immun (1994) 1.21
The iron superoxide dismutase of Legionella pneumophila is essential for viability. J Bacteriol (1994) 1.18